MultiPharm HealthCare Boldenone 10 amps (10x 200 mg/ml)

Boldenone Undecylenate - EQUIPOISE

Equipoise (boldenone undecylenate) is a well-known anabolic steroid marketed under various names such as Boldénone, Ganabol, and Ultragan. This synthetic compound mimics testosterone but is strictly intended for veterinary medicine, having never received approval for human use in North America. Its popularity surged among culturistes due to its potent effects.

Pharmacologie

Boldenone serves as a powerful anabolic agent at lower doses and exhibits both anabolic and androgenic effects at higher doses. While a calorie-rich diet can bolster growth, the steroid can inhibit natural testosterone synthesis, resulting in decreased libido and impaired spermatogenesis. At elevated doses, it may convert to estrogen, leading to gynecomastia and water retention.

Additionally, Equipoise promotes erythropoiesis, enhancing red blood cell production which improves oxygen delivery. Its prolonged half-life, unlike other stéroïdes, allows it to remain detectable in the body for 12-15 months, due to its binding affinity to tissues.

Les culturistes

The route from equine applications to human use remains unclear. However, boldenone’s potent anabolic effects and low androgenic activity make it favorable for muscle building. Although designed for animals, many bodybuilders leverage it for its muscle-enhancing properties and often stack it with other stéroïdes anabolisants. Its extended half-life allows for usage during the off-season to minimize detection.

While the weight gain from Boldénone typically takes 4-8 weeks, it primarily yields muscle mass rather than water weight. Most users prefer cycles of around 8 weeks, noting that gains tend to be sustainable over time.

Dosage

No approved human dosage guidelines exist, leading to rough estimates based on equine needs. Common dosages for bodybuilders range from 200-800 mg/week, with an average of 400 mg/week recommended. Administered via IM injection, it cannot be taken orally and should be injected cautiously to avoid pain. Women typically use about 50-75 mg/week.

Injections should be distributed among different sites to minimize discomfort, rotating between the buttocks and thighs, while avoiding the arms due to pain sensitivity.

Effets secondaires

As with all stéroïdes anabolisants, Boldénone carries risks, including:

• Peau grasse
• Acne and hair loss
• Mood fluctuations—aggression, paranoia, depression
• Rétention d'eau
• Edema
• Hypertension
• Fatigue
• Gynécomastie à fortes doses
• Atrophie testiculaire
• Potential liver damage

The side effects may persist even after discontinuation, prolonging issues like acne and oily skin.

Contre-indications

Although Boldénone is generally non-toxic, it is contraindicated for individuals who:

• Are pregnant
• Have a history of prostate or breast cancer
• Experience liver issues
• Have cardiovascular disease
• Are facing renal failure
• Suffer from hypercalcemia

Avertissements

All stéroïdes anabolisants carry risk factors, including liver damage, reduced libido, and testicular shrinkage. Users should be aware of potential mood swings, aggression, and behavioral changes following extended use.

Overdosage

Overdosing on Boldénone is unlikely, but symptoms may include nausea and abdominal cramps, requiring medical attention for monitoring and liver enzyme assessment.

Contaminants

The illicit nature of the anabolic steroid market has resulted in counterfeit products being prevalent. Many vendors sell contaminated or fake formulations, particularly online. Previously available tablets are no longer trustworthy, as they often contain mixtures of other substances. Always source Boldénone from reputable sources to avoid scams.

Contrôle

Classified as a Schedule 3 drug under the Controlled Substances Act, Boldénone is illegal for human use.

Détection

This compound’s extended half-life can result in its presence in the body for months or even years, with metabolites detectable up to 12 months post-use. Athletes must carefully consider the implications of administering Boldénone prior to competitions, as it is banned across all sporting organizations and routinely tested for.